Cardiac Complication Leads FDA to Place Foghorn Cancer Drug

A clinical trial for a Foghorn Therapeutics cancer drug is under a partial FDA hold after a patient in the early-stage study developed a cardiovascular complication. It’s the biotech’s second partial hold in the past year.

Related Keywords

Massachusetts , United States , Cambridge , Cambridgeshire , United Kingdom , , Foghorn Therapeutics , Massachusetts Based Foghorn , Weight Loss , Obesity , Verweight , Diabetes , Medical Devices , Startups , Healthcare Innovation , Medcity News , San Francisco , Life Sciences , Accelerator , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Dc , Healthcare It , Washington , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery , Aser Surgery , Dealflow , Hospitals , Wellpoint , Ealthways , Ealth And Wellness , Mployee Wellness Programs , Investing , Wellness , Medtronic , Hanghai Innovation Center , China , R D , Mdt , Minneapolis , Minnesota , Publics , Twin Cities , Ulcerative Colitis , Abbott Labs , Humira , Doctors , Pharmaceuticals , Skin Disorders , D Anderson Cancer Center , Cancer , Texas , Renal Denervation , St Jude Medical , Stj , Emr , Hr , Electronic Health Records , Electronic Medical Records , Certified Emr , Ehr , Advanced Cellular Technology , Amyotrophic Lateral Sclerosis , Embryonic Stem Cells , Geron Corporation , Lou Gehrigs Disease , Macular Degeneration , Regenerative Medicine , Spinal Cord Damage , Value Based Healthcare System , Obamacare , Ee For Service Model , California , Cleveland , Health Insurance , Insurance , Ohio , Pennsylvania , Politics , Cancer Treatment Options Library , Aetna , Pet , Aet , Health It , Phi , Philadelphia , Biopharma Nl , Dancer , Clinical Trials , Fda ,